ChaMP-CMD: A Phenotype-Blinded, Randomized Controlled, Cross-Over Trial

医学 心绞痛 氨氯地平 随机对照试验 雷诺嗪 内科学 心脏病学 运动测验 加拿大心血管学会 冠状动脉疾病 心率 血压 心肌梗塞
作者
Aish Sinha,Haseeb Rahman,Abdel Douiri,Ozan M. Demir,Kalpa De Silva,Brian Clapp,Ian Webb,Ankur Gulati,Pedro Pinho,Utkarsh Dutta,Howard Ellis,Ajay M. Shah,Amedeo Chiribiri,Michael Marber,David J. Webb,Divaka Perera
出处
期刊:Circulation [Lippincott Williams & Wilkins]
卷期号:149 (1): 36-47 被引量:8
标识
DOI:10.1161/circulationaha.123.066680
摘要

BACKGROUND: Angina with nonobstructive coronary arteries is a common condition for which no effective treatment has been established. We hypothesized that the measurement of coronary flow reserve (CFR) allows identification of patients with angina with nonobstructive coronary arteries who would benefit from anti-ischemic therapy. METHODS: Patients with angina with nonobstructive coronary arteries underwent blinded invasive CFR measurement and were randomly assigned to receive 4 weeks of amlodipine or ranolazine. After a 1-week washout, they crossed over to the other drug for 4 weeks; final assessment was after the cessation of study medication for another 4 weeks. The primary outcome was change in treadmill exercise time, and the secondary outcome was change in Seattle Angina Questionnaire summary score in response to anti-ischemic therapy. Analysis was on a per protocol basis according to the following classification: coronary microvascular disease (CMD group) if CFR<2.5 and reference group if CFR≥2.5. The study protocol was registered before the first patient was enrolled (International Standard Randomised Controlled Trial Number: ISRCTN94728379). RESULTS: Eighty-seven patients (61±8 years of age; 62% women) underwent random assignment (57 CMD group and 30 reference group). Baseline exercise time and Seattle Angina Questionnaire summary scores were similar between groups. The CMD group had a greater increment (delta) in exercise time than the reference group in response to both amlodipine (difference in delta, 82 s [95% CI, 37–126 s]; P <0.001) and ranolazine (difference in delta, 68 s [95% CI, 21–115 s]; P =0.005). The CMD group reported a greater increment (delta) in Seattle Angina Questionnaire summary score than the reference group in response to ranolazine (difference in delta, 7 points [95% CI, 0–15]; P =0.048), but not to amlodipine (difference in delta, 2 points [95% CI, –5 to 8]; P =0.549). CONCLUSIONS: Among phenotypically similar patients with angina with nonobstructive coronary arteries, only those with an impaired CFR derive benefit from anti-ischemic therapy. These findings support measurement of CFR to diagnose and guide management of this otherwise heterogeneous patient group.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
无花果应助morena采纳,获得10
2秒前
lqy发布了新的文献求助10
2秒前
科研鼠完成签到,获得积分10
3秒前
呆瓜完成签到,获得积分10
3秒前
肉肉完成签到,获得积分10
3秒前
开心的BILL发布了新的文献求助10
4秒前
清脆的巧凡应助ijoy采纳,获得20
4秒前
4秒前
6秒前
7秒前
脑洞疼应助土豆淀粉采纳,获得10
8秒前
震动的世开完成签到,获得积分10
9秒前
lbyscu完成签到 ,获得积分10
9秒前
呆瓜发布了新的文献求助10
9秒前
lqy完成签到,获得积分20
9秒前
活泼水桃发布了新的文献求助10
9秒前
听南发布了新的文献求助10
10秒前
孢子发布了新的文献求助10
10秒前
11秒前
张 大头完成签到,获得积分10
11秒前
12秒前
aczqay完成签到,获得积分10
12秒前
开心的BILL完成签到,获得积分10
13秒前
Joel完成签到,获得积分10
13秒前
14秒前
15秒前
16秒前
执着的日记本完成签到 ,获得积分10
16秒前
善学以致用应助han采纳,获得10
16秒前
16秒前
17秒前
ltt发布了新的文献求助10
17秒前
Joel发布了新的文献求助30
19秒前
小琦无敌发布了新的文献求助10
19秒前
19秒前
jj完成签到,获得积分10
20秒前
小粉完成签到,获得积分20
20秒前
21秒前
星辰大海应助ltt采纳,获得10
21秒前
土豆淀粉发布了新的文献求助10
22秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Effective Learning and Mental Wellbeing 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3975953
求助须知:如何正确求助?哪些是违规求助? 3520269
关于积分的说明 11201866
捐赠科研通 3256738
什么是DOI,文献DOI怎么找? 1798436
邀请新用户注册赠送积分活动 877578
科研通“疑难数据库(出版商)”最低求助积分说明 806464